Joyce A. O’Shaughnessy, MD: For HER2-negative breast cancers, we really have a new subtype, a new subset, of breast cancers, and those are breast cancers that have a mutation in BRCA1 or BRCA2. That’s ...

The model suggests that negative KRAS findings are believable when the maximum of APC and TP53 frequencies is at least 8% (corresponding posterior probability of false negative <5%). Validation ...

Please provide your email address to receive an email when new articles are posted on . African American women with triple-negative breast cancer had similar tumor mutational landscape as white women ...